Zarrin Hossain January 05, 2022 Type 2 diabetes (T2D) is associated with a number of risk factors and now new research, published in Diabetes Care, suggests that increased levels of liver fat and a smaller pancreas volume may also add to a greater risk of developing T2D. Head of Research Communications at Diabetes UK, Dr. Lucy Chambers, commented that this breakthrough...
Tag: <span>Diabetes</span>
Post
New study could inform treatment and prevent heart attack in diabetic patients
by Baker Heart and Diabetes Institute Myocardial Infarction or Heart Attack. Credit: Blausen Medical Communications/Wikipedia/CC-A 3.0 A new study by researchers at the Baker Heart and Diabetes Institute and Monash University could help inform treatment and prevent serious events like a heart attack or death in diabetic patients at high risk of serious cardiovascular events....
Post
Researchers working on injection-free cell therapy for diabetes
In a person with type 1 diabetes, the body mistakenly attacks pancreatic cells that produce insulin, a hormone responsible for regulating blood sugar. Without insulin, serious and eventually fatal symptoms will occur. Yet, imagine if, instead of needing daily insulin injections, people with diabetes could have insulin-producing cells placed back into the body, fixing the problem...
Post
Newly identified hormone may be a critical driver of type 1 and type 2 diabetes
by Harvard T.H. Chan School of Public Health Credit: Unsplash/CC0 Public Domain A newly discovered hormone named fabkin helps regulate metabolism and may play an important role in the development of both type 1 and type 2 diabetes, according to research led by the Sabri Ülker Center for Metabolic Research at Harvard T.H. Chan School of...
Post
Diabetes drug dapagliflozin may benefit patients with heart failure
by Melissa Rohman, Northwestern University Effects of dapagliflozin on selected secondary endpoints and in supportive responder analysis. a–c, Effects of dapagliflozin on selected secondary endpoints and in supportive responder analysis. Effects of dapagliflozin versus placebo at 12 weeks on 6MWT distance (a), KCCQ-CS responder analysis (b) and KCCQ-OS (c). Data are presented as mean values with 95%...
Post
Experimental drugs clear zombie-like cells and apply brakes to diabetes
By Nick Lavars A new study has shown how insulin resistance in diabetes could be tackled through experimental senolytic drugs that target zombie-like cellsUgreen/Depositphotos VIEW 1 IMAGES Zombie-like cells that have stopped dividing in the human body and accumulate as we age, known as senescent cells, continue to find themselves at the center of all kinds of...
Post
Researchers report novel findings for breast cancer patients with obesity, diabetes
by Boston University School of Medicine Three-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014 by Tom Misteli, Ph.D., and Karen Meaburn, Ph.D. at the NIH IRP. Obesity, insulin resistance and Type 2 diabetes are risk factors for breast cancer...
Post
Deleting dysfunctional cells alleviates diabetes
by University of Connecticut Credit: CC0 Public Domain Eliminating old, dysfunctional cells in human fat also alleviates signs of diabetes, researchers from UConn Health report. The discovery could lead to new treatments for Type 2 diabetes and other metabolic diseases. The cells in your body are constantly renewing themselves, with older cells aging and dying as...
Post
Isolation severely impacts diabetes management
New research has found that patients’ self-management of their diabetes has suffered during the COVID-19 pandemic, particularly during periods of self-isolation. A study led by Anglia Ruskin University (ARU), published in the journal Diabetology and Metabolic Syndrome, surveyed 679 adult patients between May and November 2020 and found that self-isolation was associated with greater fluctuations of blood glucose levels,...
Post
A drug that does double duty in treating diabetes
by Yale University Credit: Yale School of Engineering and Applied Science Yale researchers have developed an oral medication to treat diabetes that controls insulin levels while simultaneously reversing the inflammatory effects of the disease. The results were recently published in Nature Biomedical Engineering. Developed by Tarek Fahmy, associate professor of biomedical engineering, the drug has two critical...